Maravai LifeSciences Holdings, Inc. Share Price & Technical Analysis
MRVI · $4.40 (-1.79%)
Healthcare / Biotechnology
$4.40
-1.79%
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
19% return in May, 3% avg return in past 3 year May month.
43% return in 2026, -32% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 3% | 9% | -20% | 32% | 19% | – | – | – | – | – | – | – | 43% |
| 25 | -11% | -35% | -31% | -9% | 10% | 9% | -4% | 4% | 21% | 11% | 16% | -11% | -30% |
| 24 | -11% | 33% | 13% | -6% | 6% | -19% | 35% | -6% | -8% | -11% | -24% | -5% | -3% |
| 23 | 2% | 1% | -5% | -1% | -8% | -4% | -9% | -9% | -4% | -30% | -26% | 29% | -63% |
| 22 | -31% | 32% | -10% | -13% | 3% | -9% | -8% | -20% | 23% | -35% | -11% | -4% | -83% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.71B
P/E ratio
—
52W high
$5.00
52W low
$1.99
Volume
22,35,693
Beta
0.62
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Maravai LifeSciences Holdings, Inc. share price today?
- Maravai LifeSciences Holdings, Inc. (MRVI) last traded around $4.40 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MRVI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MRVI. Download the app for real-time alerts.
- How can I analyze Maravai LifeSciences Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.